Latest News

Submitted by Anonymous (not verified) on 21 June, 2017 - 11:54
Malcolm Weir Heptares

Japanese owned biotech joins march into Cambridge cluster

Japanese owned Heptares Therapeutics is relocating to the Cambridge life science cluster from its current base in Welwyn.

Read full article online

Kymab Dr Sonia Quaratino

Former Novartis and Merck ace is Kymab’s first CMO

Anbtibodies powerhouse Kymab has appointed immunologist Dr Sonia Quaratino as its first chief medical officer. Dr Quaratino (pictured) will manage the clinical development of the...
Read full article online

LifeArc Tapolczay

East of England springboard for new £500m medical fund

LifeArc, the UK medical research charity previously known as MRC Technology, is investing up to £500 million in the next five years to generate, fund and champion innovations in...
Read full article online

Jean de La Verpilliere

Cambridge backs assault on battery tech market

Cambridge University spin-out Echion Technologies is making great strides towards commercialising its lithium ion battery technology and is picking up accolades along the way.

Read full article online

cyanconnode, radio mesh networks, Cambridge

Cyan earns extra $3.9m from Bangladesh deal

Cambridge UK CleanTech business CyanConnode has clinched a $3.9 million bonus from an extended contract in Bangladesh.

Read full article online

consort medical, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis

Consort Medical almost doubles profits and hikes dividend

Drug and delivery device business Consort Medical plc almost doubled pre-tax profits to £21.9 million in the year to April 30 on revenues 6.2 per cent ahead at £294m.

Read full article online

Elena Mora telescope

Students use smart technology for space exploration

Smart technology deployed by Milton Keynes-based Open University is set to prove out of this world for STEM students.

Read full article online

AF Anglia Farmers Jon Duffy

AF Group boosts turnover against backdrop of lower commodity prices

Farming powerbroker AF Group has reported continued growth with turnover increasing £3.3 million to £234.2m in the past 12 months.

Read full article online

abzena, cambridge, biopharma, antibodies

Abzena revenues surge signals major expansion in the US

A handsome spike in revenues layered on top of recent fundraising success is triggering significant expansion in the US for Cambridge life science business Abzena.

Read full article online